CDI Scientists ID ‘Unconventional’ New Pathway For TB Vaccines

An “unconventional” immune response now identified by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) is a potential new pathway for developing new vaccines for tuberculosis (TB), according to a new publication.

Marginal zone B (MZB) cells are a natural response to TB infection which has...